“Philips’ innovation strength is powering our drive to provide integrated solutions that improve people's health across the health continuum,” said Frans van Houten, CEO of Royal Philips. “I am pleased that we have once again been recognized, for the 7th consecutive year, as a Derwent Top 100 Global Innovator by Clarivate Analytics. I remain convinced that our ongoing commitment to innovation and R&D, combined with our sense of purpose and culture of customer centricity, will continue to drive our mission to make the world healthier and more sustainable.”
Philips’ EUR 1.9 billion R&D program has resulted in the introduction of many successful innovations, including the new Incisive CT imaging platform for radiology departments, helping them to improve the patient and staff experience, enable smart clinical decision-making and increase efficiency, and the Ingenia Ambition 1.5T MRI system, which enables helium-free operations while delivering superb image quality. Philips also launched the new IntelliVue MX750 and MX850 patient monitors, which feature a wide range of measurements and analytics together with innovative new cybersecurity capabilities. In oral care, the company rolled out its connected Sonicare ExpertClean – a new smart power toothbrush that delivers superior oral care results with sonic technology and deep clean brushing modes.
The Derwent Top 100 Global Innovators™ 2020 report and a full list of the Top 100 organizations named in it can be found here.
 The Derwent Top 100 Global Innovators tracks innovation based on four indicators: 1. Volume: The organization must have had at least 100 granted inventions (and more than 500 filed in total) in the past five years. 2. Influence: The level of downstream impact by being highly cited externally by other organizations, and measured via the Derwent Patent Citations Index over the last five years, excluding citations from themselves. 3. Success: A high ratio of success in obtaining patent grants. 4. Globalization: The level of investment of a patent applicant in their invention, as tracked via the process of pursuing protection in all four of the key market patent offices of China, Europe, Japan, and the United States.